The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 356:425-426 January 25, 2007 Number 4
NextNext

Cardiac Tamponade after Ovarian Stimulation

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
To the Editor: The ovarian hyperstimulation syndrome is a potentially lethal complication of the administration of gonadotropin for the induction of ovulation. The condition occurs in up to 5% of patients undergoing in vitro fertilization.1 Typical manifestations include marked ovarian enlargement associated with shifts in extravascular fluid, leading to ascites and pleural and pericardial effusion.

We report a case of cardiac tamponade in a 27-year-old woman after ovarian stimulation (administration of follicle-stimulating hormone at a daily dose of 75 IU for 15 days, gonadotropin-releasing hormone antagonist at a single dose of 3 mg, and human chorionic gonadotropin at a dose . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.